Fevia Diarrhea Control Capsule, Liquid Filled
NDC Package 82706-028-01
Package Information
Fevia Diarrhea Control (bismuth subsalicylate) capsules is a medication used to treat occasional upset stomach, heartburn, and nausea. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Vivunt Pharma Llc, this product is identified by NDC 82706-028 and is authorized under FDA application M008.
Identification & Billing
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Oral - Administration to or by way of the mouth.
Regulatory & Marketing
Hierarchy Structure
- 82706 - Vivunt Pharma Llc
- 82706-028 - Fevia Diarrhea Control
- 82706-028-01 - 1 BOTTLE in 1 CARTON / 48 CAPSULE, LIQUID FILLED in 1 BOTTLE
- 82706-028 - Fevia Diarrhea Control
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (82706-028). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82706-028-01 identifies a specific commercial package of 1 bottle in 1 carton / 48 capsule, liquid filled in 1 bottle of Fevia Diarrhea Control, a human over the counter drug labeled by Vivunt Pharma Llc. This capsule, liquid filled is formulated for oral use and contains bismuth subsalicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Vivunt Pharma Llc on February 18, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat occasional upset stomach, heartburn, and nausea. It is also used to treat diarrhea and help prevent travelers' diarrhea. It works by helping to slow the growth of bacteria that might be causing the diarrhea. This product should not be used to self-treat diarrhea if you also have a fever or blood/mucus in the stools. These could be signs of a serious health condition. Consult your doctor promptly for proper evaluation and treatment if you have these symptoms. This medication is used under a doctor's direction with other medication to treat stomach ulcers caused by a certain bacteria (Helicobacter pylori). Do not use this medication to self-treat ulcers. Bismuth subsalicylate is a salicylate. Salicylates can cause serious bleeding problems when used alone in patients with ulcers. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.
How is this Vivunt Pharma Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82706002801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.